Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders - Proceedings of a Workshop (Paperback)

Psychiatric illnesses - such as major depressive disorder, anxiety disorder, substance use disorder, and posttraumatic stress disorder (PTSD) - are widely prevalent and represent a substantial health burden worldwide. Yet, conventional medications for mental illnesses often fail to provide relief to patients' disruptive and disabling symptoms. Existing and emerging evidence that psychedelics (e.g., LSD and psilocybin) and entactogens (e.g., MDMA) may be useful as tools to alleviate mental illness has sparked a renaissance of interest by investigators, clinicians, drug developers, and patient advocates in recent years. While promising data on therapeutic efficacy has energized research and development, resolving the mechanisms of action will be important for optimizing the efficacy and safety of these medicines. Further, evaluating the effect of psychedelics and entactogens on mood and behavior comes with unique challenges still in need of resolution. These include unresolved questions relating to blinding, placebo and nocebo effects, and the impact of psychosocial contexts. In response to this renewed interest, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders convened a workshop on March 29-30, 2022. The workshop brought together a diverse group of stakeholders to explore the use of psychedelics and entactogens as treatments for psychiatric disorders. This Proceedings of a Workshop summarizes the presentations and discussions of the workshop. Table of Contents Front Matter 1 Introduction and Background 2 History and Current Status of Psychedelics and Entactogens for the Treatment of Psychiatric Disorders 3 Mechanisms of Action and Key Research Gaps for Psychedelics and Entactogens 4 Advancing Clinical Development: Challenges and Opportunities 5 Anticipating Implementation to Guide Clinical Research and Development 6 Reflecting on the Road Ahead Appendix A: References Appendix B: Workshop Agenda

General

Imprint:	National Academies Press
Country of origin:	United States
Release date:	December 2022
Authors:	National Academies of Sciences, Engineering, and Medicine • Health and Medicine Division • Board on Health Sciences Policy • Forum on Neuroscience and Nervous System Disorders
Editors:	Clare Stroud • Sheena M. Posey Norris • Chanel Matney • Lisa Bain
Dimensions:	229 x 152mm (L x W)
Format:	Paperback
Pages:	96
ISBN-13:	978-0-309-69137-6
Categories:	Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
LSN:	0-309-69137-0
Barcode:	9780309691376

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!